Alkem Lab

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE540L01014
NSEID: ALKEM
BSEID: 539523
View on NSE | View on BSE

INR

5,592.40

21.7 (0.39%)

BSENSE

Jul 06, 03:30 PM

BSE+NSE Vol: 85.54 k

{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,592.40",
    "chg": 21.7,
    "chgp": "0.39%",
    "dir": 1,
    "prev_price": "5,570.70",
    "mcapval": "66,865.53 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Jul 06, 03:30 PM",
    "curr_time": "15:32 PM",
    "last_traded_at": "Jul 06, 03:30 PM IST",
    "bse_nse_vol": "85.54 k",
    "exc_status": "Active",
    "traded_date": "Jul 06, 2026",
    "traded_date_str": "2026 07 06",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4090017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_technicaldot_4090017.png",
        "date": "2026-07-06 08:03:25",
        "description": "Alkem Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Alkem Laboratories Ltd Valuation Shifts to Fair Amidst Strong Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-to-fair-amidst-strong-market-performance-4089901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_valuationdot_4089901.png",
        "date": "2026-07-06 08:01:24",
        "description": "Alkem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating as of 30 June 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical sector landscape, with key valuation multiples such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting relative to historical averages and peer benchmarks."
      },
      {
        "title": "Alkem Laboratories Gains 2.84%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-gains-284-6-key-factors-driving-the-weeks-momentum-4088696",
        "imagepath": "",
        "date": "2026-07-04 14:00:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Jun:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>30 Jun:</strong> Mojo Score upgraded to Hold as technicals improve</p>\n                    <p><strong>1 Jul:</strong> Technical momentum signals mildly bullish outlook</p>\n                    <p><strong>2 Jul:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>3 Jul:</strong> Sharp open interest surge amid rising market activity</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,416.70</div></div>\n        ..."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Rising Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-rising-market-activity-4087962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4087962.png",
        "date": "2026-07-03 15:00:14",
        "description": "Alkem Laboratories Ltd (ALKEM) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and evolving investor positioning. The pharmaceutical mid-cap stock’s open interest jumped by 18.7% to 14,179 contracts, reflecting increased speculative and hedging activity amid a backdrop of steady price gains and improving technical trends."
      },
      {
        "title": "Alkem Laboratories Sees Significant Open Interest Surge Amid Rising Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amid-rising-market-activity-4087916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4087916.png",
        "date": "2026-07-03 14:00:16",
        "description": "Alkem Laboratories Ltd has witnessed a notable 16.2% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This surge accompanies a modest price recovery and improved trading volumes, suggesting renewed confidence in the mid-cap pharmaceutical player amid a cautiously optimistic sector backdrop."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Rising Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-rising-market-activity-4087872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4087872.png",
        "date": "2026-07-03 13:00:15",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and evolving investor positioning. The pharmaceutical mid-cap stock’s open interest jumped by 15.92% to 13,849 contracts, reflecting increased speculative and hedging activity amid a backdrop of steady price gains and improving technical indicators."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Positive Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-positive-market-momentum-4087815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4087815.png",
        "date": "2026-07-03 12:00:13",
        "description": "Alkem Laboratories Ltd (ALKEM) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap stock’s open interest rose by 15.11% to 13,752 contracts, accompanied by robust volume and positive price action, suggesting renewed bullish sentiment after a brief correction."
      },
      {
        "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-4083960",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_technicaldot_4083960.png",
        "date": "2026-07-02 08:08:09",
        "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of early July 2026. Despite a modest day decline of 0.13%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes. This analysis delves into the recent changes in key technical parameters including MACD, RSI, moving averages, and other momentum indicators, providing investors with a comprehensive view of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alkem Laboratories Ltd Upgraded to Hold as Technicals Improve and Valuation Adjusts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-upgraded-to-hold-as-technicals-improve-and-valuation-adjusts-4081032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_mojoScore_4081032.png",
        "date": "2026-07-01 08:22:23",
        "description": "Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 30 June 2026, reflecting a notable improvement in technical indicators and a shift to fair valuation metrics. Despite some recent financial headwinds, the company’s market performance and operational efficiency have supported this reassessment, signalling a more balanced outlook for investors in the pharmaceuticals and biotechnology sector."
      }
    ],
    "total": 611,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Jul-2026",
      "details": "Please find attached herewith the copy of Newspaper Publication.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI LODR",
      "datetime": "01-Jul-2026",
      "details": "Please Find Attached herewith disclosure in respect of order passed by the Statutory Authority.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jun-2026",
      "details": "Please find attached herewith Copy of Newspaper Publication.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alkem Laboratories Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook

2026-07-06 08:03:25

Alkem Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors in the pharmaceuticals and biotechnology sector.

Read full news article

Alkem Laboratories Ltd Valuation Shifts to Fair Amidst Strong Market Performance

2026-07-06 08:01:24

Alkem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating as of 30 June 2026. This change reflects evolving market perceptions amid a competitive pharmaceutical sector landscape, with key valuation multiples such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios adjusting relative to historical averages and peer benchmarks.

Read full news article

Alkem Laboratories Gains 2.84%: 6 Key Factors Driving the Week’s Momentum

2026-07-04 14:00:53

Key Events This Week

29 Jun: Technical momentum shifts amid mixed indicator signals

30 Jun: Mojo Score upgraded to Hold as technicals improve

1 Jul: Technical momentum signals mildly bullish outlook

2 Jul: Technical momentum shifts amid mixed market signals

3 Jul: Sharp open interest surge amid rising market activity

Week Open

Rs.5,416.70

...

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Rising Market Activity

2026-07-03 15:00:14

Alkem Laboratories Ltd (ALKEM) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and evolving investor positioning. The pharmaceutical mid-cap stock’s open interest jumped by 18.7% to 14,179 contracts, reflecting increased speculative and hedging activity amid a backdrop of steady price gains and improving technical trends.

Read full news article

Alkem Laboratories Sees Significant Open Interest Surge Amid Rising Market Activity

2026-07-03 14:00:16

Alkem Laboratories Ltd has witnessed a notable 16.2% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This surge accompanies a modest price recovery and improved trading volumes, suggesting renewed confidence in the mid-cap pharmaceutical player amid a cautiously optimistic sector backdrop.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Rising Market Activity

2026-07-03 13:00:15

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market participation and evolving investor positioning. The pharmaceutical mid-cap stock’s open interest jumped by 15.92% to 13,849 contracts, reflecting increased speculative and hedging activity amid a backdrop of steady price gains and improving technical indicators.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Positive Market Momentum

2026-07-03 12:00:13

Alkem Laboratories Ltd (ALKEM) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap stock’s open interest rose by 15.11% to 13,752 contracts, accompanied by robust volume and positive price action, suggesting renewed bullish sentiment after a brief correction.

Read full news article

Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-02 08:08:09

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of early July 2026. Despite a modest day decline of 0.13%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes. This analysis delves into the recent changes in key technical parameters including MACD, RSI, moving averages, and other momentum indicators, providing investors with a comprehensive view of the stock’s current positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Alkem Laboratories Ltd Upgraded to Hold as Technicals Improve and Valuation Adjusts

2026-07-01 08:22:23

Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold as of 30 June 2026, reflecting a notable improvement in technical indicators and a shift to fair valuation metrics. Despite some recent financial headwinds, the company’s market performance and operational efficiency have supported this reassessment, signalling a more balanced outlook for investors in the pharmaceuticals and biotechnology sector.